Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia.
Tan T, Cabrita IZ, Hensman D, Grogono J, Dhillo WS, Baynes KC, Eliahoo J, Meeran K, Robinson S, Nihoyannopoulos P, Martin NM.
Tan T, et al.
Clin Endocrinol (Oxf). 2010 Sep;73(3):369-74. doi: 10.1111/j.1365-2265.2010.03827.x. Epub 2010 Jun 9.
Clin Endocrinol (Oxf). 2010.
PMID: 20550538
There was only one case of tricuspid regurgitation, which was mild and observed in a cabergoline-treated patient. Nodular thickening of the right coronary cusp, noncoronary cusp or left coronary cusp of the aortic valve was observed …
There was only one case of tricuspid regurgitation, which was mild and observed in a cabergoline-treated patient. Nodular thickeni …